Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 31, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 800 | $10.17 | 278,215 | |
| Jan 31, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 800 | $10.17 | 278,215 | |
| Jan 31, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 400 | $10.18 | 278,615 | |
| Jan 31, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 400 | $10.18 | 278,615 | |
| Jul 07, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 64,601 | $9.03 | 279,336 | |
| Jan 03, 2024 | Chief People Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 11,650 | $13.53 | 279,507 | |
| Jan 31, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,300 | $10.19 | 279,915 | |
| Jan 31, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,300 | $10.19 | 279,915 | |
| Jan 09, 2024 | Chief People Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4/A | 13,684 | -- | 280,389 | |
| Aug 01, 2022 | Chief Legal Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 11,123 | $10.02 | 280,707 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.